Table 4.
Change in health state utility after hearing aid fitting and ICER with 95% Confidence Interval (CI) (n = 70)
| Measure | Mean | Standard deviation | Median | Interquartile range | Minimum | Maximum | ICERa €/QALY | (95% CI) €/QALY |
|---|---|---|---|---|---|---|---|---|
| EQ-5D UK tariff | 0.01 | 0.13 | 0.00 | 0.04 | −0.60 | 0.27 | 286,866 | (inferiorb–47,082) |
| EQ-5D Dutch tariff | 0.00 | 0.12 | 0.00 | 0.04 | −0.60 | 0.28 | 647,209 | (inferiorb–61,934) |
| HUI2 | 0.07* | 0.13 | 0.08** | 0.12 | −0.50 | 0.40 | 25,337 | (19,356–38,012) |
| HUI3 | 0.12* | 0.18 | 0.13** | 0.22 | −0.22 | 0.60 | 15,811 | (11,664–24,654) |
* Statistically significant; Paired t-test; P < 0.01
** Statistically significant: Wilcoxon Signed-Rank test; P < 0.01
a ICER based on mean scores
b Inferior means higher costs and lower utility